Guangfa Zhu
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 1
- Modeling and Simulation top 5%
- Neurology top 10%
-
- Venous Thromboembolism Diagnosis and Management 2
-
- Cardiac tumors and thrombi 4
- Cardiovascular Disease and Adiposity 1
-
- Pulmonary Hypertension Research and Treatments 4
-
- Orthopedic Infections and Treatments 3
-
- Infective Endocarditis Diagnosis and Management 3
-
- Antibiotic Resistance in Bacteria 2
- Partner nations
- ChinaUnited StatesAustria
In The Last Decade
Guangfa Zhu
15 papers receiving 557 citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Infectious Diseases 368
- Modeling and Simulation 66
- Neurology 169
- Internal Medicine 18
- General Dentistry 8
Countries citing papers authored by Guangfa Zhu
This map shows the geographic impact of Guangfa Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangfa Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangfa Zhu more than expected).
Fields of papers citing papers by Guangfa Zhu
This network shows the impact of papers produced by Guangfa Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangfa Zhu. The network helps show where Guangfa Zhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guangfa Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 5 | |
| 4 | 2022 | 4 | |
| 5 | 2022 | 0 | |
| 6 | 2020 | 14 | |
| 7 | 2020 | 13 | |
| 8 | Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, Chinabreakdown → | 2020 | 475 |
| 9 | 2019 | 1 | |
| 10 | 2018 | 1 | |
| 11 | 2017 | 22 | |
| 12 | 2016 | 16 | |
| 13 | 2016 | 9 | |
| 14 | 2016 | 0 | |
| 15 | [Diagnosis and surgical treatment of pulmonary artery sarcoma]. | 2014 | 1 |
| 16 | 2014 | 6 | |
| 17 | [The clinical analysis of 54 cases for the surgical treatment of pulmonary embolism]. | 2008 | 2 |
About Guangfa Zhu
Guangfa Zhu is a scholar working on Internal Medicine, Molecular Medicine and Cardiology and Cardiovascular Medicine, having authored 17 papers that have together received 572 indexed citations. Recurring topics across this work include Cardiac tumors and thrombi (4 papers), Pulmonary Hypertension Research and Treatments (4 papers), Orthopedic Infections and Treatments (3 papers), Infective Endocarditis Diagnosis and Management (3 papers), Antibiotic Resistance in Bacteria (2 papers), Venous Thromboembolism Diagnosis and Management (2 papers), SARS-CoV-2 and COVID-19 Research (1 paper) and Cardiovascular Disease and Adiposity (1 paper). The work is most often cited by research in Infectious Diseases (368 citations), Modeling and Simulation (66 citations) and Neurology (169 citations). Guangfa Zhu has collaborated with scholars based in China, United States and Austria. Frequent co-authors include Lai Wei, Lokesh Sharma, Minggui Lin, Charles S. Dela Cruz, De Chang, Lixin Xie, Dong Chen, Hui‐Li Gan, Xiaoyong Huang and Zhe Zhang. Their work appears in journals such as JAMA, CHEST Journal and Clinical Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.